Skip to main content
Log in

A comparison of the effects of oral dydrogesterone and levonorgestrel-releasing intrauterine device on quality of life and sexual function in patients with abnormal uterine bleeding

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

The purpose of this study is to compare the effects of cyclic oral dydrogesterone treatment and levonorgestrel-releasing intrauterine device (LNG_IUD) on quality of life (QoL) and sexual function in patients diagnosed with abnormal uterine bleeding (AUB).

Study design

The study was conducted at the University of Health Sciences Turkey Health Istanbul Kanuni Sultan Süleyman Training and Research Hospital, on 171 sexually active patients, aged 18–45, who were under a minimum of 6 months of treatment for AUB. 85 patients were treated with oral cyclic dydrogesterone, and 86 patients received LNG-IUD. Following a minimum of 6 months of treatment, these patients were recruited to the study and were asked to complete a 36-Item Short Form Survey (SF-36) and the Female Sexual Function Index (FSFI).

Results

When the FSFI scores of the patients were compared, it was observed that the total FSFI score was significantly higher in the cyclic dydrogesterone group (p < 0.05). Likewise, it was observed that sexual desire, arousal, and lubrication domains were significantly higher in the cyclic dydrogesterone group (p < 0.05). No significant differences were found between the treatment groups in 7 out of the 8 dimensions of SF-36. The energy/vitality dimension was found to be significantly higher in the cyclic dydrogesterone group.

Conclusion

Total FSFI score, as well as sexual desire, arousal, and lubrication scores, were significantly higher in the cyclic dydrogesterone group compared to the LNG-IUD group indicating that cyclic dydrogesterone has a more positive impact on sexual function when compared to LNG-IUD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The dataset used for the current study is available from the corresponding author upon reasonable request.

References

  1. Matthews ML (2015) Abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol Clin North Am 42(1):103–115

    Article  PubMed  Google Scholar 

  2. Munro MG, Critchley HO, Broder MS, Fraser IS (2011) FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 113(1):3–13

    Article  PubMed  Google Scholar 

  3. Marnach ML, Laughlin-Tommaso SK (2019) Evaluation and management of abnormal uterine bleeding. Mayo Clin Proc 94(2):326–335

    Article  PubMed  Google Scholar 

  4. Liu Z, Doan QV, Blumenthal P, Dubois RW (2007) A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 10(3):183–194

    Article  PubMed  Google Scholar 

  5. Heliövaara-Peippo S, Hurskainen R, Teperi J, Aalto AM, Grénman S, Halmesmäki K et al (2013) Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial. Am J Obstet Gynecol 209(6):535 e1-e14

    Article  PubMed  Google Scholar 

  6. Benetti-Pinto CL, Rosa ESA, Yela DA, Soares Júnior JM (2017) Abnormal uterine bleeding. Rev Bras Ginecol Obstet 39(7):358–368

    Article  PubMed  PubMed Central  Google Scholar 

  7. Marjoribanks J, Lethaby A, Farquhar C (2006) Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2:Cd003855

    Google Scholar 

  8. Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Kujansuu E et al (2007) The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial. BJOG 114(5):563–568

    Article  PubMed  Google Scholar 

  9. Podzolkova N, Tatarchuk T, Doshchanova A, Eshimbetova G, Pexman-Fieth C (2016) Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecol Endocrinol 32(3):246–249

    Article  CAS  PubMed  Google Scholar 

  10. Gorgen H, Api M, Akça A, Cetin A (2009) Use of the levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet 279:835–840

    Article  PubMed  Google Scholar 

  11. Bastianelli C, Farris M, Benagiano G (2011) Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contracept 84(4):402–8

    Article  Google Scholar 

  12. Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J (2013) Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 368(2):128–137

    Article  CAS  PubMed  Google Scholar 

  13. Yalçın Bahat P, Yücel B, Yuksel Ozgor B, Kadiroğulları P, Topbas Selçuki NF, Çakmak K et al (2022) The effect of dydrogesterone on sexual function in endometriosis. J Obstet Gynaecol 42(5):1276–1279

    Article  PubMed  Google Scholar 

  14. Backman T (2004) Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf 27(15):1185–1204

    Article  CAS  PubMed  Google Scholar 

  15. Mittermeier T, Farrant C, Wise MR (2020) Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Cochrane Database Syst Rev 9(9):Cd012658

    PubMed  Google Scholar 

  16. Goshtasebi A, Moukhah S, Gandevani SB (2013) Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid. Arch Gynecol Obstet 288(5):1055–1060

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all our study subjects for participating in this study.

Funding

None received.

Author information

Authors and Affiliations

Authors

Contributions

RA: manuscript writing/editing, protocol/project development, data collection or management NFT: data collection or management, manuscript writing/editing, data analysis OK: manuscript writing/editing, data analysis PYB: protocol/project development, data analysis, manuscript writing/editing.

Corresponding author

Correspondence to Ozan Karadeniz.

Ethics declarations

Conflict of interest

No potential conflict of interest was reported by the authors. The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abul, R., Selcuki, N.F.T., Karadeniz, O. et al. A comparison of the effects of oral dydrogesterone and levonorgestrel-releasing intrauterine device on quality of life and sexual function in patients with abnormal uterine bleeding. Arch Gynecol Obstet 309, 715–719 (2024). https://doi.org/10.1007/s00404-023-07315-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-023-07315-y

Keywords

Navigation